Effects of chitosan pentamer and chitosan hexamer in vivo and in vitro on gene expression and secretion of cytokines
Authors: Wei, Xinlin1; Wang, Yuanfeng1; Zhu, Qing2; Xiao, Jianbo1; Xia, Wenshui3
Source: Food and Agricultural Immunology, Volume 20, Number 3, September 2009 , pp. 269-280(12)
Publisher: Taylor and Francis Ltd
Abstract:
Effects of chitosan pentamer ((GLcN)5) and chitosan hexamer ((GLcN)6) in vivo and in vitro on gene transcription and protein translation of interleukin-1 (IL-1), tumour necrosis, factor alpha (TNF-α), interleukin-2 and interferon-γ (IFN-γ) were investigated by relatively quantitative reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay. The results showed that the expression of IL-1 mRNA, TNF-α mRNA, IFN-γ mRNA as well as the secretion of IL-1, TNF-α and IFN-γ can both be promoted by (GLcN)6 and (GLcN)5. The promotion effects caused by (GLcN)6 were greater than that of (GLcN)5. Gene transcription and protein secretion of cytokines were promoted by (GLcN)5 and (GLcN)6 in vivo and in vitro and thus the immuno-modulating ability was promoted. This may be one of the molecular mechanisms for elucidation of immunity of chitooligosaccharides.Keywords: chitosan pentamer; chitosan hexamer; cytokines; gene expression; secretion
Document Type: Research article
DOI: http://dx.doi.org/10.1080/09540100903168157
Affiliations: 1: College of Life and Environment Science, Shanghai Normal University, Shanghai, P.R. China 2: School of Basic Medical Science, Nantong University, Nantong, P.R. China 3: State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, P.R. China
Publication date: 2009-09-01
- Editorial Board
- Information for Authors
- Subscribe to this Title
- ingentaconnect is not responsible for the content or availability of external websites
- In this: publication
- By this: publisher
- In this Subject: Nutrition & Food , Microbiology
- By this author: Wei, Xinlin ; Wang, Yuanfeng ; Zhu, Qing ; Xiao, Jianbo ; Xia, Wenshui

Shopping cart
Receive new issue alert